Back to Search
AMY JO SANTIN MD
MD
Family Medicine Physician
NPI: 1184829855IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
201000076(NC)
Education
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Class of 2007
Research & Publications (20)
Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu.
PMID 18555254·Int J Gynaecol Obstet·2008
5-case
Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial.
PMID 18057249·J Virol·2008
3-trial
Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).
PMID 17326053·Cancer·2007
7-preclinical
Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomas.
PMID 17545541·Clin Cancer Res·2007
7-preclinical
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
PMID 16249018·Gynecol Oncol·2006
8-other
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
PMID 16647913·Am J Obstet Gynecol·2006
8-other
Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
PMID 15867230·Clin Cancer Res·2005
4-observational
Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy.
PMID 16248803·Curr Pharm Des·2005
6-review
Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
PMID 15899825·Cancer Res·2005
7-preclinical
Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma.
PMID 16116605·Cancer·2005
4-observational
Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.
PMID 15746676·Am J Obstet Gynecol·2005
8-other
Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy.
PMID 15785748·Br J Cancer·2005
8-other
Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.
PMID 15629771·Virology·2005
8-other
Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization.
PMID 15894362·Gynecol Oncol·2005
4-observational
Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling.
PMID 15208622·Br J Cancer·2004
4-observational
The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cells.
PMID 15297163·Gynecol Oncol·2004
7-preclinical
Increased levels of gangliosides in the plasma and ascitic fluid of patients with advanced ovarian cancer.
PMID 15198791·BJOG·2004
3-trial
Current treatment options for endometrial cancer.
PMID 15270671·Expert Rev Anticancer Ther·2004
6-review
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
PMID 15305371·Int J Cancer·2004
4-observational
Influence of allogeneic blood transfusion on clinical outcome during radiotherapy for cancer of the uterine cervix.
PMID 12867765·Gynecol Obstet Invest·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1542 CANE CREEK RD
FLETCHER, NC 28732 - Phone
- (828) 628-8250
Quick Facts
- NPI
- 1184829855
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile